Compliance with drug therapy.
Open Access
- 1 November 1991
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 32 (5) , 535-539
- https://doi.org/10.1111/j.1365-2125.1991.tb03948.x
Abstract
Although no single method is ideal for measuring compliance the methods now available allow accurate assessment of compliance in most settings. Studies using new and more accurate methods of measuring compliance have shown poor compliance to be an even greater problem than was previously thought. Using these methods, efforts in the future should be directed at relating compliance to treatment outcome, and investigating whether manoeuvres aimed at improving compliance actually improve patient outcome.Keywords
This publication has 9 references indexed in Scilit:
- The prediction of steady‐state plasma phenobarbitone concentrations (following low‐dose phenobarbitone) to refine its use as an indicator of compliance.British Journal of Clinical Pharmacology, 1991
- A comparison of a short half‐life marker (low‐dose isoniazid), a long half‐life pharmacological indicator (low‐dose phenobarbitone) and measurements of a controlled release ‘therapeutic drug’ (metoprolol, Metoros) in reflecting incomplete compliance by volunteers.British Journal of Clinical Pharmacology, 1990
- Treatment adherence and risk of death after a myocardial infarctionThe Lancet, 1990
- Compliance with Short-Term High-Dose Ethinyl Oestradiol in Young Patients with Primary InfertilityPublished by Springer Nature ,1990
- The natural history of medication compliance in a drug trial: Limitations of pill countsClinical Pharmacology & Therapeutics, 1989
- How Often Is Medication Taken as Prescribed?JAMA, 1989
- Compliance in clinical trials: impact on design, analysis and interpretation.1988
- Does the frequency of daily dosage influence compliance with digoxin therapy?British Journal of Clinical Pharmacology, 1981